thromboplastin and Puerperal-Disorders

thromboplastin has been researched along with Puerperal-Disorders* in 5 studies

Other Studies

5 other study(ies) available for thromboplastin and Puerperal-Disorders

ArticleYear
Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, Jul-06, Volume: 96, Issue:14

    We employed a novel mouse line that expresses low levels of human tissue factor (TF) in the absence of murine TF to analyze the role of TF in gestation. Low-TF female mice had a 14-18% incidence of fatal postpartum uterine hemorrhage, suggesting that TF plays an important role in uterine hemostasis. Low-TF female mice mated with low-TF male mice had a 42% incidence of fatal midgestational hemorrhage (n = 41), whereas no fatal midgestational hemorrhages were observed in low-TF female mice mated with wild-type male mice (n = 43). Placentas of low-TF embryos from both low-TF and normal (+/-) TF females were abnormal and contained numerous maternal blood pools in the labyrinth. Placentas of TF null embryos surviving beyond embryonic day 10.5 exhibited similar defects. The mouse maternal-embryonic placental barrier consists of four cellular layers (layers I, II, and III and endothelial cells), where layer I lines the maternal lacunae. Comparison of TF-deficient placentas with control placentas by immunohistochemical and ultrastructural analyses revealed thinning of layer I and a reduction in the number of cellular contacts of layer I trophoblasts spanning the maternal blood space between adjacent trabeculae. These structural changes in low-TF and TF null placentas result in enlarged maternal lacunae, as determined by morphometric analysis, and placental hemorrhage, which leads to midgestational death of low-TF female mice. This study demonstrated that TF is required for uterine hemostasis and revealed an unexpected role of TF in the maintenance of the placental labyrinth.

    Topics: Animals; Crosses, Genetic; Female; Hemostasis; Humans; Male; Mice; Mice, Knockout; Placenta; Pregnancy; Puerperal Disorders; Thromboplastin; Uterine Hemorrhage; Uterus

1999
Disseminated intravascular coagulation.
    Current practice in obstetric and gynecologic nursing, 1978, Volume: 2

    Topics: Blood Coagulation; Disseminated Intravascular Coagulation; Female; Humans; Hypoxia; Pregnancy; Pregnancy Complications; Puerperal Disorders; Thromboplastin; Toxins, Biological

1978
Further studies on the abnormal factor X (factor X Friuli) coagulation disorder: a report of another family.
    Blood, 1971, Volume: 37, Issue:5

    Topics: Adult; Antibodies; Antigens; Appendectomy; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Transfusion; Factor VII; Factor X; Female; Hematuria; Hemorrhage; Heterozygote; Humans; Hypoprothrombinemias; Immunodiffusion; Italy; Neutralization Tests; Pedigree; Phosphatidylethanolamines; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Thromboplastin; Tooth Extraction

1971
[Morphology and pathogenesis of the so-called puerpereal myocardiosis].
    Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie, 1967, Volume: 110, Issue:3

    Topics: Adult; Cardiomyopathies; Coronary Disease; Female; Fetomaternal Transfusion; Humans; Myocardium; Pregnancy; Puerperal Disorders; Thromboplastin

1967
[CONSIDERATIONS OF THE DELIVERY AND PUERPERIUM OF A SUBJECT AFFECTED BY ANGIOHEMOPHILIA B].
    Quaderni di clinica ostetrica e ginecologica, 1963, Volume: 18

    Topics: Blood Coagulation Tests; Delivery, Obstetric; Female; Hemophilia B; Humans; Pathology; Postpartum Period; Pregnancy; Puerperal Disorders; Thromboplastin; von Willebrand Diseases

1963